Prerana Bangalore Parthasarathy (Prerana Parthasarathy, Prerana B Parthasarathy)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Neural Stem Cells

Top Venues

Science immunology

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Ruchika Verma, Tyler J Alban, Prerana Bangalore Parthasarathy, Mojgan Mokhtari, Paula Toro Castano, Mark L Cohen, Justin D Lathia, Manmeet Ahluwalia, Pallavi Tiwari
Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning. Science advances 10 (34) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Ruchika Verma, Tyler J Alban, Prerana Bangalore Parthasarathy, Mojgan Mokhtari, Paula Toro Castano, Mark L Cohen, Justin D Lathia, Manmeet Ahluwalia, Pallavi Tiwari
Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning. Science advances 10 (34) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Ruchika Verma, Tyler J Alban, Prerana Bangalore Parthasarathy, Mojgan Mokhtari, Paula Toro Castano, Mark L Cohen, Justin D Lathia, Manmeet Ahluwalia, Pallavi Tiwari
Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning. Science advances 10 (34) (2024)
Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler J Alban, Ivan Juric, Juan Dong, Prerana Bangalore Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian R Gastman, Timothy A Chan, Li Lily Wang
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science immunology 9 (95) (2024)
Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, Carley Mitchell, Paul G Pavicic, Pingfu Fu, Amit Rupani, Hana Husic, Patricia A Rayman, Shadi Swaidani, Jame Abraham, George T Budd, Halle C F Moore, Zahraa Al-Hilli, Jennifer Susan Ko, Joseph Baar, Timothy A Chan, Tyler J Alban, C Marcela Diaz-Montero, Alberto J Montero
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)